S Jacqueminet

Summary

Country: France

Publications

  1. doi request reprint [Management of gestational diabetes]
    S Jacqueminet
    CHU Pitie Salpetriere, Service de diabétologie et maladies métaboliques, 47 83 boulevard de l Hopital, 75013 Paris, France
    J Gynecol Obstet Biol Reprod (Paris) 39:S251-63. 2010
  2. ncbi request reprint Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy
    S Jacqueminet
    Service de Diabetologie, Groupe Hospitalier Pitie Salpetriere, 47 83 boulevard de l Hopital, F75651 Paris Cedex 13, France
    Clin Chim Acta 367:103-7. 2006
  3. doi request reprint Therapeutic management of gestational diabetes
    S Jacqueminet
    CHU Pitie Salpetriere, Service de diabétologie et maladies métaboliques, 47 83, Boulevard de l Hopital, 75013 Paris, France
    Diabetes Metab 36:658-71. 2010
  4. doi request reprint Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes
    J Lepercq
    Service de Gynecologie Obstetrique, Hopital Cochin Saint Vincent de Paul, AP HP, 82, avenue Denfert Rochereau, 75674 Paris Cedex 14, France
    Diabetes Metab 36:209-12. 2010
  5. ncbi request reprint Outcome of severe diabetic foot ulcers after standardised management in a specialised unit
    A Hartemann-Heurtier
    Department of Diabetology and Metabolism, Pitié Salpêtrière Teaching Hospital, Paris, France
    Diabetes Metab 28:477-84. 2002
  6. ncbi request reprint Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors
    S Jacqueminet
    Service de diabétologie et métabolisme, Hopital Pitie Salpetriere, Paris, France
    Diabetes Metab 31:370-5. 2005
  7. ncbi request reprint Limitations of the so-called "intensified" insulin therapy in type 1 diabetes mellitus
    S Jacqueminet
    Service de diabétologie métabolisme, Groupe Hospitalier Pitié Salpêtrèbre, Paris, France
    Diabetes Metab 31:4S45-4S50. 2005

Detail Information

Publications7

  1. doi request reprint [Management of gestational diabetes]
    S Jacqueminet
    CHU Pitie Salpetriere, Service de diabétologie et maladies métaboliques, 47 83 boulevard de l Hopital, 75013 Paris, France
    J Gynecol Obstet Biol Reprod (Paris) 39:S251-63. 2010
    ..Maternal and perinatal complications linked to gestational diabetes could be decreased with an intensive treatment...
  2. ncbi request reprint Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy
    S Jacqueminet
    Service de Diabetologie, Groupe Hospitalier Pitie Salpetriere, 47 83 boulevard de l Hopital, F75651 Paris Cedex 13, France
    Clin Chim Acta 367:103-7. 2006
    ..We investigated whether circulating levels of MMP-9 and TIMP-1 are altered in diabetic retinopathy and whether they might serve as biological markers of ocular complications in type 1 diabetes...
  3. doi request reprint Therapeutic management of gestational diabetes
    S Jacqueminet
    CHU Pitie Salpetriere, Service de diabétologie et maladies métaboliques, 47 83, Boulevard de l Hopital, 75013 Paris, France
    Diabetes Metab 36:658-71. 2010
    ..Maternal and perinatal complications linked to gestational diabetes mellitus could be decreased with an intensive management approach...
  4. doi request reprint Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes
    J Lepercq
    Service de Gynecologie Obstetrique, Hopital Cochin Saint Vincent de Paul, AP HP, 82, avenue Denfert Rochereau, 75674 Paris Cedex 14, France
    Diabetes Metab 36:209-12. 2010
    ..The aim of this study was to examine the safety of insulin glargine during pregnancy in women with type 1 diabetes mellitus (T1DM)...
  5. ncbi request reprint Outcome of severe diabetic foot ulcers after standardised management in a specialised unit
    A Hartemann-Heurtier
    Department of Diabetology and Metabolism, Pitié Salpêtrière Teaching Hospital, Paris, France
    Diabetes Metab 28:477-84. 2002
    ..The secondary objective was to retrospectively identify the factors that influenced time to healing...
  6. ncbi request reprint Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors
    S Jacqueminet
    Service de diabétologie et métabolisme, Hopital Pitie Salpetriere, Paris, France
    Diabetes Metab 31:370-5. 2005
    ..To evaluate the outcomes of severe ischemic diabetic foot ulcers for which percutaneous transluminal angioplasty (PTA) was considered as the first-line vascular procedure. Factors associated with successful PTA were sought...
  7. ncbi request reprint Limitations of the so-called "intensified" insulin therapy in type 1 diabetes mellitus
    S Jacqueminet
    Service de diabétologie métabolisme, Groupe Hospitalier Pitié Salpêtrèbre, Paris, France
    Diabetes Metab 31:4S45-4S50. 2005
    ..Patient empowerment is the key to the success of functional insulin treatment...